Format

Send to

Choose Destination
See comment in PubMed Commons below
Eur Heart J. 2014 Jul;35(26):1712-8. doi: 10.1093/eurheartj/eht464. Epub 2013 Dec 2.

Treating hypertension in the very elderly-benefits, risks, and future directions, a focus on the hypertension in the very elderly trial.

Author information

1
School of Public Health, Imperial College London, London, UK.
2
Department of Ageing and Health, Guys' and St Thomas' Foundation NHS Trust, Westminster Bridge Road, London SE1 7EH, UK Department of Medicine, Imperial College London, London, UK nigel.beckett@gstt.nhs.uk.
3
Whitby Group Practice, Whitby, UK.
4
Catholic University of Leuven, Leuven, Belgium.
5
Faculty of Epidemiology and Public Health, London School of Hygiene and Tropical Medicine, London, UK.
6
Department of Medicine, Imperial College London, London, UK.

Abstract

Although the number of individuals reaching 80 who are considered to be healthy is increasing, the very elderly are likely to have long-term conditions, to report symptoms and/or be taking at least one regular medication. The impact of antihypertensive treatment has to be taken into account in this context. The treatment regimen in Hypertension in the Very Elderly Trial with a goal blood pressure of <150/80 mmHg has been shown to provide benefits in terms of a reduction in risk of total mortality, stroke, and cardiovascular events with potential benefits and no evidence of increased risk for fracture, dementia, depression, and quality-of-life outcomes. Questions remain as to the level of benefit that would be accrued in the frailer elderly and those at extreme age, for example, over 90.

KEYWORDS:

Aged; Antihypertensives; Benefit; Elderly; Hypertension; Risk

PMID:
24302270
DOI:
10.1093/eurheartj/eht464
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Support Center